Takeda Pulls US BLA For Dengue Vaccine

Cites Issues Around 'Data Collection'

 
• By Lisa Takagi and Ian Haydock
  
Takeda's TAK-003, also known as Qdenga, was granted Priority Review from the US FDA in November 2022.
Takeda's dengue vaccine granted priority review in the US in November 2022 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip